{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:36Z","timestamp":1786372896939,"version":"build-2736575974"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.2215\/cjn.00540110","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T23:45:03Z","timestamp":1274744703000},"page":"1141-1160","source":"Crossref","is-referenced-by-count":6,"title":["Nephrology Quiz and Questionnaire"],"prefix":"10.2215","volume":"5","author":[{"given":"Richard J.","family":"Glassock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Bargman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biff F.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20230601","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/089686080802800217","article-title":"Acinetobacter peritoneal dialysis peritonitis: Description and relation to the SPICE family of organisms","volume":"28","author":"Friedman","year":"2008","journal-title":"Perit Dial Int"},{"key":"R2-26-20230601","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14787210.6.5.671","article-title":"Clinical significance of extended-spectrum beta-lactamases","volume":"6","author":"Rodriguez-Bano","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R3-26-20230601","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1086\/430789","article-title":"Extended-spectrum beta-lactamases","volume":"41","author":"Turner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-26-20230601","first-page":"401","article-title":"Extended-spectrum beta-lactamases: Implications for the clinical laboratory and therapy","volume":"28","author":"Harada","year":"2008","journal-title":"Korean J Lab Med"},{"key":"R5-26-20230601","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1177\/089686080902902S31","article-title":"Update on fungal peritonitis and its treatment","volume":"29","author":"Matuszkiewicz-Rowinska","year":"2009","journal-title":"Perit Dial Int"},{"key":"R6-26-20230601","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/089686080602600518","article-title":"Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients","volume":"26","author":"Chou","year":"2006","journal-title":"Perit Dial Int"},{"key":"R7-26-20230601","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0272-6386(96)90135-3","article-title":"Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes","volume":"28","author":"Goldie","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R8-26-20230601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0272-6386(12)80249-6","article-title":"Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: Six years' experience","volume":"17","author":"Zaruba","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R9-26-20230601","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/089686080702700512","article-title":"Prevention of fungal peritonitis with nystatin in patients receiving CAPD","volume":"27","author":"Wong","year":"2007","journal-title":"Perit Dial Int"},{"key":"R10-26-20230601","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/089686089901900614","article-title":"Pain due to peritonitis","volume":"19","author":"Piraino","year":"1999","journal-title":"Perit Dial Int"},{"key":"R11-26-20230601","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(05)72593-9","article-title":"Allergic reactions to icodextrin in patients with renal failure","volume":"355","author":"Divino Filho","year":"2000","journal-title":"Lancet"},{"key":"R12-26-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/089686080202200401","article-title":"Icodextrin-associated sterile peritonitis","volume":"22","author":"Gokal","year":"2002","journal-title":"Perit Dial Int"},{"key":"R13-26-20230601","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/039139880502800807","article-title":"Pharmacokinetics of intraperitoneal cefazolin and ceftazidime co-administered to CAPD patients","volume":"28","author":"Elwell","year":"2005","journal-title":"Int J Artif Organs"},{"key":"R15-26-20230601","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-127-4-199708150-00003","article-title":"Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis","volume":"127","author":"Marr","year":"1999","journal-title":"Ann Intern Med"},{"key":"R16-26-20230601","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0272-6386(99)70018-1","article-title":"Bacteremia associated with tunnelled, cuffed hemodialysis catheters","volume":"34","author":"Saad","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R17-26-20230601","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.V7102264","article-title":"A clustering of epidural abscesses in chronic hemodialysis patients: Risks of salvaging access catheters in cases of infection","volume":"7","author":"Kovalik","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R18-26-20230601","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000071479","article-title":"Routine replacement of tunneled, cuffed, hemodialysis catheters eliminates paraspinal\/vertebral infections in patients with catheter-associated bacteremia","volume":"23","author":"Philipneri","year":"2003","journal-title":"Am J Nephrol"},{"key":"R19-26-20230601","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2215\/CJN.01840309","article-title":"Bacteremia associated with tunnelled hemodialysis catheters: Outcome after attempted salvage","volume":"4","author":"Ashby","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-26-20230601","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/039139889101400306","article-title":"Septicemia in long-term jugular hemodialysis catheters: Eradicating infection by changing the catheter over a guidewire","volume":"14","author":"Carlisle","year":"1991","journal-title":"Int J Artif Organs"},{"key":"R21-26-20230601","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0272-6386(95)90129-9","article-title":"Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: Management by guidewire exchange","volume":"25","author":"Shaffer","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R22-26-20230601","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1046\/j.1523-1755.1998.00954.x","article-title":"Treatment of infected tunnelled venous access hemodialysis catheters with guidewire exchange","volume":"53","author":"Robinson","year":"1998","journal-title":"Kidney Int"},{"key":"R23-26-20230601","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1046\/j.1523-1755.2000.00067.x","article-title":"Bacteremia associated with tunnelled dialysis catheters: Comparison of two treatment strategies","volume":"57","author":"Tanriover","year":"2000","journal-title":"Kidney Int"},{"key":"R24-26-20230601","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfi104","article-title":"Tunnelled haemodialysis catheter bacteraemia: Risk factors for bacteraemia recurrence, infectious complications and mortality","volume":"21","author":"Mokrzycki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R25-26-20230601","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/ndt\/17.6.1149","article-title":"Treatment of haemodialysis catheter-related infections","volume":"17","author":"Vardhan","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R26-26-20230601","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfh041","article-title":"Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen","volume":"19","author":"Poole","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R27-26-20230601","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2007.04.014","article-title":"Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: A quality improvement report","volume":"50","author":"Maya","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R28-26-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/0004563001901344","article-title":"Screening for surreptitious laxative abuse","volume":"37","author":"Duncan","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"R29-26-20230601","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/BF01297195","article-title":"Acid-base disturbances in gastrointestinal disease","volume":"32","author":"Perez","year":"1987","journal-title":"Dig Dis Sci"},{"key":"R30-26-20230601","first-page":"451","article-title":"Laxative abuse syndrome","volume":"4","author":"Oster","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"R31-26-20230601","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(17)39923-8","article-title":"Laxative abuse as a cause for ammonium urate renal calculi","volume":"143","author":"Dick","year":"1990","journal-title":"J Urol"},{"key":"R32-26-20230601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/snep.2003.50007","article-title":"Renal stones in the tropics","volume":"23","author":"Robertson","year":"2003","journal-title":"Semin Nephrol"},{"key":"R33-26-20230601","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1373\/clinchem.2006.077883","article-title":"Factitious diarrhea induced by stimulant laxatives: Accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography","volume":"53","author":"Shelton","year":"2007","journal-title":"Clin Chem"},{"key":"R34-26-20230601","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s004670050378","article-title":"Gentamicin-induced Bartter-like syndrome","volume":"11","author":"Landau","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"R35-26-20230601","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0272-6386(12)81064-X","article-title":"Acute muscular paralysis in an adult with subclinical Bartter's syndrome associated with gentamicin administration","volume":"24","author":"Shiah","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R36-26-20230601","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000441-200503000-00007","article-title":"Acquired Bartter-like syndrome associated with gentamicin administration","volume":"329","author":"Chou","year":"2005","journal-title":"Am J Med Sci"},{"key":"R37-26-20230601","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.ki.5001654","article-title":"Dysregulation of renal sodium transporters in gentamicin-treated rats","volume":"70","author":"Sassen","year":"2006","journal-title":"Kidney Int"},{"key":"R38-26-20230601","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2009.17","article-title":"Fluid, electrolyte and acid-base disorders associated with antibiotic therapy","volume":"5","author":"Zietse","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R39-26-20230601","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jjp.88.69","article-title":"Human organic anion transporters mediate the transport of tetracycline","volume":"88","author":"Babu","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R40-26-20230601","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archneur.1981.00510100078014","article-title":"Downbeat nystagmus with magnesium depletion","volume":"38","author":"Saul","year":"1981","journal-title":"Arch Neurol"},{"key":"R41-26-20230601","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.51.5.1478","article-title":"Periodic downbeat nystagmus","volume":"51","author":"Du Pasquier","year":"1998","journal-title":"Neurology"},{"key":"R42-26-20230601","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","article-title":"Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathies haemolytic anaemias","volume":"120","author":"Allford","year":"2003","journal-title":"Br J Haematol"},{"key":"R43-26-20230601","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"key":"R44-26-20230601","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.03270906","article-title":"Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome","volume":"2","author":"Kavanagh","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-26-20230601","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic sydrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R46-26-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2006-939771","article-title":"Membrane cofactor protein and factor I: Mutations and transplantation","volume":"32","author":"Kavanagh","year":"2006","journal-title":"Semin Thromb Haemost"},{"key":"R47-26-20230601","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"R48-26-20230601","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"R49-26-20230601","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1523-1755.2002.00543.x","article-title":"Post-transplant hemolytic-uremic syndrome","volume":"62","author":"Ruggenenti","year":"2002","journal-title":"Kidney Int"},{"key":"R50-26-20230601","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R51-26-20230601","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"R52-26-20230601","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"R53-26-20230601","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome","volume":"20","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R54-26-20230601","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-199805270-00023","article-title":"Recurrence of hemolytic uremic syndrome in renal transplant recipients","volume":"65","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"R55-26-20230601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient","volume":"53","author":"Chan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R56-26-20230601","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria: An addition to the Banff'97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R57-26-20230601","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1111\/j.1600-6143.2006.01574.x","article-title":"From humoral rejection to generalized thrombotic microangiopathy: Role of acquired ADAMST-13 deficiency in a renal allograft recipient [erratum appears in Am J Transplant 7: 730, 2007]","volume":"6","author":"Ulinski","year":"2006","journal-title":"Am J Transplant"},{"key":"R58-26-20230601","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00007890-200210270-00003","article-title":"Inhibitors of ADAMST13: A potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient","volume":"74","author":"Pham","year":"2002","journal-title":"Transplantation"},{"key":"R59-26-20230601","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/ajkd.2000.17690","article-title":"Cyclosporine and tacrolimus-associated thrombotic microangiopathy","volume":"36","author":"Pham","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R60-26-20230601","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-transplant assessment of donor reactive, HLA-specific antibodies in renal transplantation: contraindication vs risk","volume":"3","author":"Gebel","year":"2003","journal-title":"Am J Transplant"},{"key":"R61-26-20230601","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.humimm.2006.07.011","article-title":"Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays: Single center experience","volume":"67","author":"Mihaylova","year":"2006","journal-title":"Hum Immunol"},{"key":"R62-26-20230601","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJM199911043411906","article-title":"The economic implications of HLA matching in cadaveric renal transplantation","volume":"341","author":"Schnitzler","year":"1999","journal-title":"N Engl J Med"},{"key":"R63-26-20230601","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/01.TP.0000090865.20886.B7","article-title":"Three-year post-transplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen","volume":"76","author":"Irish","year":"2003","journal-title":"Transplantation"},{"key":"R64-26-20230601","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/01.ASN.0000093254.31868.85","article-title":"Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients","volume":"14","author":"Irish","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R65-26-20230601","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"key":"R66-26-20230601","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1042\/bj3220919","article-title":"Antibody selection against CD52 produces paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism","volume":"322","author":"Taylor","year":"1997","journal-title":"Biochem J"},{"key":"R67-26-20230601","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1432-2277.2006.00445.x","article-title":"Hemolytic uremic syndrome following Campath-1H induction","volume":"20","author":"Bonatti","year":"2007","journal-title":"Transpl Int"},{"key":"R68-26-20230601","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"R69-26-20230601","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late-antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"R70-26-20230601","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: Subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"R71-26-20230601","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ncpneph0854","article-title":"A primer on recurrent and de novo glomerulonephritis in renal allografts","volume":"4","author":"Ivanyi","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"R72-26-20230601","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5414\/CNP71719","article-title":"Rapid onset of diabetic nephropathy in three renal allografts despite normoglycemia","volume":"71","author":"Wojciechowski","year":"2009","journal-title":"Clin Nephrol"},{"key":"R73-26-20230601","first-page":"324","article-title":"Monoclonal immunoglobulin light chain-related renal diseases","volume":"13","author":"Sanders","year":"1993","journal-title":"Semin Nephrol"},{"key":"R74-26-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.ajkd.2007.05.007","article-title":"Renal manifestations of plasma cell disorders","volume":"50","author":"Leung","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R75-26-20230601","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2215\/CJN.01600408","article-title":"Renal lesions associated with IgM-secreting monoclonal proliferations: Revisiting the disease spectrum","volume":"3","author":"Audard","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R77-26-20230601","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"R78-26-20230601","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"R79-26-20230601","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R80-26-20230601","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"key":"R81-26-20230601","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/BOR.0b013e3282f16c0a","article-title":"New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"20","author":"Jennette","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R82-26-20230601","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/ndt\/gfh139","article-title":"Distinguishing C1q nephropathy from lupus nephritis","volume":"19","author":"Sharman","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R83-26-20230601","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.ki.5002411","article-title":"Intra-tubular amyloidosis","volume":"72","author":"El-Zoghby","year":"2007","journal-title":"Kidney Int"},{"key":"R84-26-20230601","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MNH.0b013e3280bdc0db","article-title":"New insights into systemic amyloidosis: The importance of diagnosis of specific type","volume":"16","author":"Picken","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R85-26-20230601","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"key":"R86-26-20230601","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ng0393-252","article-title":"Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain","volume":"3","author":"Benson","year":"1993","journal-title":"Nat Genet"},{"key":"R87-26-20230601","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R88-26-20230601","first-page":"4799","article-title":"Renal amyloidosis with a frame shift mutation in fibrinogen alpha-chain gene producing a novel amyloid protein","volume":"90","author":"Hamidi Asl","year":"1997","journal-title":"Blood"},{"key":"R89-26-20230601","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/00313020600820823","article-title":"Hereditary fibrinogen A alpha-chain amyloidosis","volume":"38","author":"Lane","year":"2006","journal-title":"Pathology"},{"key":"R90-26-20230601","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI117027","article-title":"Hereditary renal amyloidosis with a novel variant fibrinogen","volume":"93","author":"Uemichi","year":"1994","journal-title":"J Clin Invest"},{"key":"R91-26-20230601","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1600-6143.2005.01199.x","article-title":"Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen A alpha-chain gene","volume":"6","author":"Mousson","year":"2006","journal-title":"Am J Transplant"},{"key":"R92-26-20230601","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/qjmed\/93.5.269","article-title":"Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family","volume":"93","author":"Gillmore","year":"2000","journal-title":"QJM"},{"key":"R93-26-20230601","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/CCO.0b013e32801494c6","article-title":"Transplantation for amyloidosis","volume":"19","author":"Gertz","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R94-26-20230601","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2005.05.010","article-title":"Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis","volume":"46","author":"Leung","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R95-26-20230601","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMe078027","article-title":"Advances in the treatment of amyloidosis","volume":"356","author":"Rajkumar","year":"2007","journal-title":"N Engl J Med"},{"key":"R96-26-20230601","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.2004.05232.x","article-title":"High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: A single centre prospective phase II study","volume":"127","author":"Perz","year":"2004","journal-title":"Br J Haematol"},{"key":"R97-26-20230601","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"R98-26-20230601","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0049-0172(96)80012-6","article-title":"The changing face of familial Mediterranean fever","volume":"26","author":"Livneh","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"R99-26-20230601","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","article-title":"Hereditary periodic fever","volume":"345","author":"Drenth","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201006000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:41Z","timestamp":1786369181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201006000-00026"}},"subtitle":["2009"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00540110","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}